NPM-ALK modulates the p53 tumour suppressor pathway in a...

NPM-ALK modulates the p53 tumour suppressor pathway in a JNK and PI 3-Kinase dependent manner: MDM-2 is a potential therapeutic target for the treatment of ALK-expressing malignancies

Y. Cui, A. Kerby, F.K.E. McDuff, S.D. Turner
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)71315-6
File:
PDF, 90 KB
english, 2008
Conversion to is in progress
Conversion to is failed